Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-008819
Filing Date
2014-02-10
Accepted
2014-02-10 18:25:07
Documents
1
Period of Report
2014-02-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4024
  Complete submission text file 0001209191-14-008819.txt   5338
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address
LeDoux Anne M (Reporting) CIK: 0001396735 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50679 | Film No.: 14590700